NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)
CUSIP: 64125C109
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 99,963,154
- Total 13F shares
- 94,376,685
- Share change
- +1,413,870
- Total reported value
- $12,879,887,685
- Put/Call ratio
- 94%
- Price per share
- $136.50
- Number of holders
- 596
- Value change
- +$230,192,847
- Number of buys
- 292
- Number of sells
- 281
Quarterly Holders Quick Answers
What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 64125C109:
Top shareholders of NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
14%
|
14,256,048
|
$1,642,581,850 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
9,996,960
|
$1,151,849,731 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
4.8%
from 13D/G
|
5,148,293
|
$593,186,319 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.6%
|
2,574,546
|
$296,639,190 | — | 30 Sep 2024 | |
| Bellevue Group AG |
13F
|
Company |
1.9%
|
1,863,800
|
$214,747,036 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
1,859,232
|
$213,772,686 | — | 30 Sep 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
1,843,281
|
$212,198,509 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
1,764,590
|
$203,316,060 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.7%
|
1,675,176
|
$193,015,000 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.5%
|
1,497,931
|
$172,591,610 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
1,349,381
|
$155,476,146 | — | 30 Sep 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.3%
|
1,316,590
|
$151,697,500 | — | 30 Sep 2024 | |
| DODGE & COX |
13F
|
Company |
1.3%
|
1,287,820
|
$148,382,620 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
1,017,154
|
$117,196,523 | — | 30 Sep 2024 | |
| DSM CAPITAL PARTNERS LLC |
13F
|
Company |
0.94%
|
944,154
|
$108,785,424 | — | 30 Sep 2024 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.94%
|
942,147
|
$108,554,177 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.94%
|
939,000
|
$108,191,580 | — | 30 Sep 2024 | |
| BRAIDWELL LP |
13F
|
Company |
0.92%
|
917,674
|
$105,734,398 | — | 30 Sep 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.89%
|
894,217
|
$103,031,682 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.87%
|
874,665
|
$100,778,957 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.86%
|
858,250
|
$98,887,622 | — | 30 Sep 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.84%
|
842,197
|
$97,029,587 | — | 30 Sep 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.82%
|
819,968
|
$94,478,000 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.79%
|
792,196
|
$91,275,517 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
771,624
|
$88,906,517 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.76%
|
763,355
|
$87,953,763 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.75%
|
747,291
|
$86,102,868 | — | 30 Sep 2024 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Individual |
0.74%
|
736,910
|
$84,906,769 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.72%
|
718,226
|
$82,754,000 | — | 30 Sep 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.69%
|
689,986
|
$79,500,240 | — | 30 Sep 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.62%
|
621,363
|
$78,130,183 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.66%
|
664,336
|
$77,355,284 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.64%
|
636,914
|
$73,385,231 | — | 30 Sep 2024 | |
| Amundi |
13F
|
Individual |
0.66%
|
656,695
|
$73,326,563 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.62%
|
623,588
|
$71,849,789 | — | 30 Sep 2024 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.58%
|
582,789
|
$67,148,949 | — | 30 Sep 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.54%
|
544,321
|
$62,716,660 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.53%
|
533,324
|
$61,449,591 | — | 30 Sep 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.52%
|
524,168
|
$60,394,637 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.52%
|
523,632
|
$60,330,814 | — | 30 Sep 2024 | |
| Fiera Capital Corp |
13F
|
Company |
0.52%
|
516,801
|
$59,545,811 | — | 30 Sep 2024 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.51%
|
512,480
|
$59,047,945 | — | 30 Sep 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.51%
|
510,089
|
$58,772,000 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.5%
|
496,094
|
$57,159,954 | — | 30 Sep 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.49%
|
492,190
|
$56,710,127 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.48%
|
483,241
|
$55,676,534 | — | 30 Sep 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.46%
|
462,147
|
$53,248,577 | — | 30 Sep 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.46%
|
460,000
|
$53,001,200 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.44%
|
437,831
|
$50,446,888 | — | 30 Sep 2024 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.42%
|
420,748
|
$48,478,585 | — | 30 Sep 2024 |
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q4 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.